Pet services marketplace Wag stock jumps 37% Aug. 22, 2022 11:50 AM ETWag! Group Co. (PET) Pet services marketplace Wag (NASDAQ:PET) stock shot up 37% in morning trading Monday. Shares of Wag opened at $6.17, sliding to an early low of $5.30 before climbing to a high of $8.33 in late morning. The stock recently changed hands at $7.10 at approximately 11:30 a.m. ET. Wag stock made its market debut on Aug. 10 following the company's merger with SPAC CHW Acquisition Corp. The deal had pegged the equity and enterprise value of the combined company at around $350M.
Well, I'm still in and underwater. The chart doesn't look that good, I still believe though. For now. I wouldn't jump in if I were you though. The dust is settling on NEOG however. Might be worth a small bite. $20.73
I had a funny moment on the plane this dude in front of me snores real bad. Such a blowhard comes on board talking plane lingo-- " hey I just flew a Z-40 phew! " He's from Boeing, He puts these noise canceling headphones on and then goes into full sleep apnia snore. Just disgusting, gargling in his own spit. I was kind of hot at that and when he went on to his neighbor about If Boeing ever hits $90 it's going out of business and his mother bought Boeing stock at such a such price,...I just wanted to scream out: GBA SHORTED YOUR ASS AT $170!!!!! GET OUT OF MY WAY!
Apple workers tell CEO Tim Cook: ‘We demand location-flexible Dildos.' Apple workers tell CEO Tim Cook: ‘We demand location-flexible sex toys’ Mon, August 22, 2022, 10:40 AM
I'm In! Quanterix Corp - Insiders Are Buying Near All-Time Lows Mon, August 22, 2022, 11:45 AM In this article: QTRX -3.18% LLY +0.56% After reaching dizzying heights during the beginning of the Covid pandemic (which is still on-going if anyone noticed!), Quanterix Corp. (NASDAQ:QTRX) has now dropped to all-time lows. This is a great example of a bubble and bust, demonstrating Mr. Market's Dr. Jekyll and Mr. Hyde personality. Quanterix Corp - Insiders Are Buying Near All-Time Lows About Quanterix Quanterix is developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The bead-based and planar array platforms (trademarked Simoa) designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has Simoa technology with the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability. Quanterixs technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious diseases. For example, it has a colloboration with Eli Lilly (NYSE:LLY) on developing new tools to diagnose, monitor and treat Alzheimer's disease. Quanterix Corp - Insiders Are Buying Near All-Time Lows Source: Company Presentation The company was established in 2007 and is located in Billerica, Massachusetts. It sells both instruments and consumables built on its technology, so it has a razor (instrument) and blade (consumables) business model. Once a lab adopts its technology and instruments, it gets locked into buying consumables. Insider trading Qunaterix caught my attention because of multiple and substantial stock purchases by key insiders as the stock went down: Oh wait no because Van said...... Quanterix Corp - Insiders Are Buying Near All-Time Lows As can be seen in the above chart, insider trading has been mostly selling in the past but now has suddenly shifted to buying. When insiders start buying shares like this, it is a sign for investors to pay attention, as insiders are in the best position to understand their company and its prospects. The insiders buying Quanterix recently include the chief financial officer and the CEO as well as several directors. The size of the trades are substantial, so this is likely not just window dressing to suck in gullible investors. The CEO recently bought $1.095 million worth of stock and the chief financial officer spent $305,000. Four separate directors including the co-founder and chairman loaded up as well. Below is a chart detailing the recent insider buys: DOYLE MICHAEL A CFO and Treasurer 2022-08-15 30,000 Buy 10.30 Toloue Masoud President & CEO 2022-08-12 105,000 Buy 10.43 Hlavinka Sarah E. Director 2022-08-11 10,160 Buy 9.89 WALT DAVID R Director/Cofouncer 2022-08-10 150,000 Buy 8.62 MEISTER PAUL M Director 2022-08-10 234,304 Buy 8.53 Madaus Martin D Director 2022-08-10 89,667 Buy 8.43 Fundamentals The company was smart to raise a lot of cash while the stock was flying high on Covid tailwinds. The balance sheet is in great shape with $360 million in cash and few liabilities. Quanterix Corp - Insiders Are Buying Near All-Time Lows The cash flow diagram below shows that the company is burning cash as it develops its technology. However, the company has several years of available cash runway to be able to fund operations. Hopefully by then, the company will be able to attain takeoff velocity to profitability. Quanterix Corp - Insiders Are Buying Near All-Time Lows Another encouraging sign is revenue continues to increase: Quanterix Corp - Insiders Are Buying Near All-Time Lows Conclusion Overall, Quanterix appears to be interesting as a long term speculation. This is a development stage company still in cash-burning mode, so it is risky. On the other hand, the company is growing revenues rapidly and has plenty of cash to fund its development. In my expereince, investments like Quanterix are a bit like lottery tickets - either they become multi-baggers or go bust, so investors should never go all-in. Insiders are buying heavily, which could mean they see the stock as undervalued. Management was smart to have raised equity capital when the stock was flying high and Mr. Market was in a bubble state. The company is also small enough that it may get acquired by a larger player in pharma or biotech.
I will not short a crowded short. I will not short a crowded short I wii not short a crowded short. I will not short a crowded short. I will not short a crowded short……. Professor Stoney, is that enough on the Elite chalkboard?